Walmsley Shakes Up GSK; Cuts More Than 30 Drug Development Programs

Blocks
Walmsley to set GSK on a new path with R&D shake up • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business